The test is seen as a significant move toward commercial supersonic flights, which could cut flight times in half. The ...

The No Surprises Act has protected patients from surprise medical bills. However, the law’s incentives for insurers acting as ...

UCB, a global biopharmaceutical company, today announced three-year data from the BE HEARD trials for BIMZELX® (bimekizumab-bkzx) in moderate-to-severe hidradenitis suppurativa (HS). BIMZELX, the ...

Discover key insights from Aon's Q3 2025 earnings call: organic growth, data center insurance opportunity, and 2025 guidance.

Building the World’s Coldest Megaproject In the far north of Siberia, where temperatures plunge to –58°F and the sun dis ...